Abstract
Quantitative isotropic diffusion MRI and voxel-based analysis of the apparent diffusion coefficient (ADC) changes have been demonstrated to be able to accurately predict early response of brain tumors to therapy. The ADC value changes measured during pre- and post-therapy interval are closely correlated to treatment response. This work was demonstrated using a voxel-based analysis of ADC change during therapy in the brains of both rats and humans, following rigidly registering pre- and post-therapeutic ADC MRI exams. The primary goal of this paper is to extend this voxel-by-voxel analysis to assess therapeutic response in breast cancer. Nonlinear registration (with higher degrees of freedom) between the pre- and post-treatment exams is needed to ensure that the corresponding voxels actually contain similar cellular partial contributions due to soft tissue deformations in the breast and compartmental tumor changes during treatment as well. With limited data sets, we have observed the correlation between changes of ADC values and treatment response also exists in breast cancers. With diffusion scans acquired at three different timepoints (pre-treatment, early post-treatment and late post-treatment), we have also shown that ADC changes across responders within 5 weeks are a function of time interval after the initiation of treatment. Comparison of the experimental results with pathology shows that ADC changes can be used to evaluate early response of breast cancer treatment.
This work is supported in part by NIH grants 1P01CA85878, 1P01CA87634, and P50CA93990.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fisher, B., Bryant, J., Wolmark, N., Mamounas, E., Brown, A., Fisher, E.R., Wickerham, D.L., Begovic, M., DeCillis, A., Robidoux, A., Margolese, R.G., Cruz Jr., A.B., Hoehn, J.L., Lees, A.W., Dimitrov, N.V., Bear, H.D.: Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Journal of Clinical Oncology 6, 2672–2685 (1998)
Kuerer, H.M., Newman, L.A., Smith, T.L., Ames, F.C., Hunt, K.K., Dhinga, K., Theriault, R.L., Singh, G., Binkley, S.M., Sneige, N., Buchholz, T.A., Ross, M.I., McNeese, M.D., Buzdar, A.U., Hortobagyi, G.N., Singletary, S.E.: Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. Journal of Clinical Oncology 17, 460–469 (1999)
Bonadonna, G., Valagussa, P., Brambilla, C., Ferrari, L., Moliterni, A., Terenziani, M., Zambetti, M.: Primary chemotherapy in operable breast cancer: eight-year experience at the Milan cancer institute. Journal of Clinical Oncology 16, 93–100 (1998)
Buchholz, T.A., Hill, B.S., Tucker, S.L., Frye, D.K., Kuerer, H.M., Buzdar, A.U., McNeese, M.D., Singletary, S.E., Ueno, N.T., Pusztai, L., Valero, V., Hortobagyi, G.N.: Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J. 7, 413–420 (2001)
Schott, A.F., Roubidoux, M.A., Helvie, M.A., Hayes, D.F., Kleer, C.G., Newman, L., Pierce, L.J., Griffith, K.A., Murray, S., Hunt, K.A., Paramagul, C., Baker, L.H.: Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res. Treat 92, 231–238 (2005)
Chenevert, T.L., Stegman, L.D., Taylor, J.M.G., Robertson, P.L., Greenberg, H.S., Rehemtulla, A., Ross, B.D.: Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J. Natl. Cancer Inst. 92(24), 2029–2036 (2000)
Moffat, B.A., Chenevert, T.L., Lawrence, T.S., Meyer, C.R., Johnson, T.D., Dong, Q., Tsien, C., Mukherji, S., Quint, D., Gebarski, S.S., Robertson, P.L., Junck, L.R., Rehemtulla, A., Ross, B.D.: Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc. Natl. Acad. Sci. USA 102(15), 5524–5529 (2005)
Ross, B.D., Moffat, B.A., Lawrence, T., Mukherji, S., Gebarski, S., Quint, D., Johnson, T.D., Junck, L., Robertson, P., Muraszko, K., Dong, Q., Meyer, C.R., Bland, P., McConville, P., Geng, H., Rehemtulla, A., Chenevert, T.L.: Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol. Cancer Therapy 2, 581–587 (2003)
Hamstra, D.J., Chenevert, T.L., Moffat, B.A., Johnson, T.D., Meyer, C.R., Mukherji, S., Quint, D.J., Gebarski, S.S., Xiaoying, F., Tsiena, C., Lawrence, T.S., Junck, L.R., Rehemtulla, A., Ross, B.D.: Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high grade glioma. Proc. Natl. Acad. Sci. USA 102(46), 16759–16764 (2005)
Chenevert, T.L., Meyer, C.R., Moffat, B.A., Rehemtulla, A., Mukherji, S.K., Gebarski, S.S., Quint, D.J., Robertson, P.L., Lawrence, T.S., Junck, L., Taylor, J.M., Johnson, T.D., Dong, Q., Muraszko, K.M., Brunberg, J.A., Ross, B.D.: Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol. Imaging 1(4), 336–343 (2002)
Lee, K.C., Hall, D.E., Hoff, B.A., Moffat, B.A., Sharma, S., Chenevert, T.L., Meyer, C.R., Leopold, W.R., Johnson, T.D., Mazurchuk, R.V., Rehemtulla, A., Ross, B.D.: Dynamic imaging of emerging resistance during cancer therapy. Cancer Res. 66(9), 4687–4692 (2006)
Lee, K.C., Moffat, B.A., Schott, A.F., Layman, R., Ellingworth, S., Juliar, R., Khan, A.P., Helvie, M.A., Meyer, C.R., Chenevert, T.L., Rehemtulla, A., Ross, B.D.: Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin. Cancer Res. 13(2), 443–450 (2007)
Lee, K.C., Sud, S., Meyer, C.R., Moffat, B.A., Chenevert, T.L., Rehemtulla, A., Pienta, K.J., Ross, B.D.: An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res. 67(8), 3524–3528 (2007)
Lee, K.C., Bradley, D., Hussain, M., Meyer, C., Chenevert, T., Jacobson, J., Johnson, T., Galbán, C., Rehemtulla, A., Pienta, K., Ross, B.: A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 9(12), 1003–1011 (2007)
Hamstra, D.A., Galbán, C.J., Meyer, C.R., Johnson, T.D., Sundgren, P.C., Tsien, C., Lawrence, T.S., Junck, L., Ross, D.J., Rehemtulla, A., Ross, B.D., Chenevert, T.L.: Functional Diffusion Map as an early imaging biomarker for high-grade glioma: Correlation with conventional radiologic response and overall survival. J. Clin. Oncol. 26(20), 3387–3394 (2008)
Ross, B.D., Chenevert, T.L., Kim, B., Ben-Joseph, O.: Magnetic resonance imaging and spectroscopy: Application to experimental neuro-oncology. Q. Magn. Reson. Biol. Med. 1, 89–106 (1994)
Meyer, C.R., Boes, J.L., Kim, B., Bland, P.H., Zasadny, K.R., Kison, P.V., Koral, K., Frey, K.A., Wahl, R.L.: Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Medical Image Analysis 1, 195–206 (1997)
Pickles, M.D., Gibbs, P., Lowry, M., Turnbull, L.W.: Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magnetic Resonance Imaging 24(7), 843–847 (2006)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Ma, B. et al. (2009). Voxel-by-Voxel Functional Diffusion Mapping for Early Evaluation of Breast Cancer Treatment. In: Prince, J.L., Pham, D.L., Myers, K.J. (eds) Information Processing in Medical Imaging. IPMI 2009. Lecture Notes in Computer Science, vol 5636. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02498-6_23
Download citation
DOI: https://doi.org/10.1007/978-3-642-02498-6_23
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02497-9
Online ISBN: 978-3-642-02498-6
eBook Packages: Computer ScienceComputer Science (R0)